Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sao Tome and Principe
Sao Tome and Principe: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 86.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sao Tome and Principe, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Sao Tome and Principe is 86.0%, measured in 2025.
The figure is down 10.4% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Sao Tome and Principe peaked at 97.0% in 2013 and was at its lowest, 0.0%, in 2008.
That places Sao Tome and Principe 92nd out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sao Tome and Principe, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 97.0% | — |
| 2014 | 95.0% | -2.1% |
| 2015 | 96.0% | +1.1% |
| 2016 | 96.0% | +0.0% |
| 2017 | 95.0% | -1.0% |
| 2018 | 95.0% | +0.0% |
| 2019 | 95.0% | +0.0% |
| 2020 | 96.0% | +1.1% |
| 2021 | 97.0% | +1.0% |
| 2022 | 92.0% | -5.2% |
| 2023 | 86.0% | -6.5% |
| 2024 | 86.0% | +0.0% |
| 2025 | 86.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 66.9% | 0.0% | 97.0% | 10 |
| 2020s | 90.5% | 86.0% | 97.0% | 6 |
Countries ranked near Sao Tome and Principe
More health data for Sao Tome and Principe
- Un projection of annual infant deaths, annual growth rate -6.25 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Heat deaths vs projected death rates 793.5 (2090)
- Un projection of annual infant deaths 15 (2100)
- Population ages 15-64, male, annual growth rate 2.46 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.2907 units per person (2025)
- Population ages 15-64, total, annual growth rate 2.58 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.586 units per person (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Sao Tome and Principe?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Sao Tome and Principe was 86.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Sao Tome and Principe?
- The highest recorded value was 97.0% in 2013.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Sao Tome and Principe?
- The lowest recorded value was 0.0% in 2008.
- How does Sao Tome and Principe rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Sao Tome and Principe ranks 92nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Sao Tome and Principe?
- Over the last ten years it is down 10.4%. The long-run trend across the full record is volatile.
- Where does this Sao Tome and Principe data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).